Growth Metrics

Biocryst Pharmaceuticals (BCRX) Non-Current Debt: 2011-2014

Historic Non-Current Debt for Biocryst Pharmaceuticals (BCRX) over the last 4 years, with Dec 2014 value amounting to $30.0 million.

  • Biocryst Pharmaceuticals' Non-Current Debt was N/A to $30.0 million in Q3 2015 from the same period last year, while for Sep 2015 it was $30.0 million, marking a year-over-year change of. This contributed to the annual value of $30.0 million for FY2014, which is negligibly% changed negligibly from last year.
  • Per Biocryst Pharmaceuticals' latest filing, its Non-Current Debt stood at $30.0 million for FY2014, which was down 0.00% from $30.0 million recorded in FY2013.
  • In the past 5 years, Biocryst Pharmaceuticals' Non-Current Debt registered a high of $30.0 million during FY2011, and its lowest value of $30.0 million during FY2011.
  • Its 3-year average for Non-Current Debt is $30.0 million, with a median of $30.0 million in 2014.